Through its establishment at Health2B, the Ahus innovation centre is making four services available to industry:
Real-World Evidence (RWE): Clarifying real needs in specialist healthcare and documenting the effect of new products in clinical practice.
Annotated and anonymised datasets: Preparing and providing high-quality health data for the development, training and validation of data-driven products and AI models.
Technical testing of security and performance: Verifying that solutions meet the strictest requirements for data security, robustness and performance.
Clinical trials: Facilitating and conducting clinical trials in real hospital settings.
A neutral arena for building trust and momentum
Health2B at Oslo Science Park brings together stakeholders from the public, private and non-profit sectors to develop a new culture and methodology for collaboration.
“We are delighted that Ahus will take an active role in the partnership and contribute to the further development of Health2B. We welcome the Ahus Innovation Centre for Artificial Intelligence (AI²) to the Health2B community. Their presence and concrete services give industry a gateway to hospital data and clinical trials in real-world settings. It is an exciting initiative to accelerate public–private collaboration,” says Elen Høeg, CEO of Health2B.
The establishment at Health2B begins immediately. The innovation centre at Ahus will continually invite industry, academic communities and start-ups to professional forums, roundtable discussions and pilot projects.